BUFFERIN Side Effects

7000490-4 | Pulmonary Fibrosis
on Sep 16, 2010 Male patient from JAPAN , 81 years of age, was treated with Bufferin (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary fibrosis (What is pulmonary fibrosis?). Bufferin dosage: .

6673147-7 | Bradycardia, Hypotension, Stent Placement
Patient was taking Bufferin (View Usage). Patient had the following side effects: bradycardia, hypotension, stent placement on Apr 01, 2010 from BRAZIL Additional patient health information: Male patient , 63 years of age, . Bufferin dosage: 81mg, Unk. Patient was hospitalized.

6589658-9 | Therapeutic Agent Toxicity
Adverse event was reported on Feb 09, 2010 by a Female patient taking Bufferin (View Usage) (Dosage: Text:3000-4000mg/d) . Location: UNITED STATES , 90 years of age, After Bufferin was administered, patient had the following side effects: therapeutic agent toxicity. During the same period patient was treated with PILOCARPINE HYDROCHLORIDE (Text:3000-4000 Mg /daily) (View Pilocarpine Hydrochloride Review and Pilocarpine Hydrochloride Label ), DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ).

6453588-3 | Toxic Epidermal Necrolysis
on Nov 11, 2009 Female patient from JAPAN , 74 years of age, was treated with Bufferin (View Usage). Patient experienced the following unwanted or unexpected effects: toxic epidermal necrolysis. Bufferin dosage: . During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ).


6291770-9 |
on Jul 21, 2009 Male patient from UNITED STATES , 83 years of age, was treated with Bufferin (View Usage). . Bufferin dosage: Oral.

6125701-9 | Altered State Of Consciousness, Blood Pressure Decreased, Cardiac Tamponade, Subdural Haematoma
Patient was taking Bufferin (View Usage). After Bufferin was administered, patient had the following side effects: altered state of consciousness, blood pressure decreased, cardiac tamponade, subdural haematoma on Mar 17, 2009 from JAPAN Additional patient health information: Male patient , 60 years of age, was diagnosed with cerebral infarction and. Bufferin dosage: . During the same period patient was treated with CILOSTAZOL (View Cilostazol Review and Cilostazol Label ). Patient was hospitalized.

6087129-X | Blood Pressure Increased, Decreased Activity, Feeling Abnormal
Adverse event was reported on Jan 28, 2009 by a Female patient taking Bufferin (View Usage) (Dosage: 1000 Mg, Qid, Oral) was diagnosed with arthritis (What is arthritis?) and. Location: UNITED STATES , 86 years of age, weighting 145.1 lb, Patient experienced the following unwanted or unexpected effects: blood pressure increased, decreased activity, feeling abnormal. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ).

6037560-3 | Anorexia, Clostridial Infection, Diarrhoea, Haematochezia
on Jan 02, 2009 Male patient from UNITED STATES , 13 years of age, was diagnosed with rheumatic fever and was treated with Bufferin (View Usage). Patient had the following side effects: anorexia, clostridial infection, diarrhoea, haematochezia. Bufferin dosage: Oral. Patient was hospitalized.

6016918-2 | Breast Cancer
on Dec 12, 2008 Female patient from UNITED STATES , 75 years of age, was diagnosed with arthritis (What is arthritis?), thrombosis prophylaxis and was treated with Bufferin (View Usage). After Bufferin was administered, patient had the following side effects: breast cancer (What is breast cancer?). Bufferin dosage: 1 Df, Bid, Oral.

5870887-4 | Systemic Lupus Erythematosus, Thrombocytopenia, Upper Gastrointestinal Haemorrhage
Patient was taking Bufferin (View Usage). Patient experienced the following unwanted or unexpected effects: systemic lupus erythematosus, thrombocytopenia, upper gastrointestinal haemorrhage on Sep 01, 2008 from JAPAN Additional patient health information: Female patient , 81 years of age, was diagnosed with angina pectoris and. Bufferin dosage: . Patient was hospitalized.

5741552-9 | Compartment Syndrome, Muscle Haemorrhage, Muscle Necrosis
Adverse event was reported on Apr 02, 2008 by a Male patient taking Bufferin (View Usage) (Dosage: Total Daily Dose: 81 Mg) was diagnosed with polycythaemia vera and. Location: JAPAN , 40 years of age, Patient had the following side effects: compartment syndrome, muscle haemorrhage, muscle necrosis. During the same period patient was treated with KELNAC (Total Daily Dose: 80 Mg) (View Kelnac Review and Kelnac Label ). Patient was hospitalized.

5738104-3 | Anaemia, Diverticulum Intestinal Haemorrhagic, Dysstasia, Renal Impairment
on May 09, 2008 Male patient from JAPAN , 73 years of age, was diagnosed with acute myocardial infarction and was treated with Bufferin (View Usage). After Bufferin was administered, patient had the following side effects: anaemia, diverticulum intestinal haemorrhagic, dysstasia, renal impairment. Bufferin dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

5562979-4 | Diverticulum Intestinal Haemorrhagic, Melaena
on Dec 04, 2007 Female patient from JAPAN , 84 years of age, was diagnosed with myocardial ischaemia, spinal column stenosis and was treated with Bufferin (View Usage). Patient experienced the following unwanted or unexpected effects: diverticulum intestinal haemorrhagic, melaena. Bufferin dosage: . During the same period patient was treated with ETODOLAC (View Etodolac Review and Etodolac Label ).

5521908-X | Corneal Perforation
Patient was taking Bufferin (View Usage). Patient had the following side effects: corneal perforation on Nov 13, 2007 from JAPAN Additional patient health information: Female patient , 79 years of age, was diagnosed with foreign body sensation in eyes, scleritis and. Bufferin dosage: Unit Dose: 81 Mg. During the same period patient was treated with LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), 0.1 HYALEIN (HYALURONIC ACID) (View 0.1 Hyalein (hyaluronic Acid) Review and 0.1 Hyalein (hyaluronic Acid) Label ), SANBETASON (BETAMETHASONE SODIUM PHOSPHATE EYE DROPS) (View Sanbetason (betamethasone Sodium Phosphate Eye-drops) Review and Sanbetason (betamethasone Sodium Phosphate Eye-drops) Label ), OMEPRAL (View Omepral Review and Omepral Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), AZULAVINE/AZ (SODIUM AZULENE SULFONATE EYE DROP) (View Azulavine/az (sodium Azulene Sulfonate Eye-drop) Review and Azulavine/az (sodium Azulene Sulfonate Eye-drop) Label ). Patient was hospitalized.

5489259-X | Blister, Dry Skin, Erythema, Lip Haemorrhage, Skin Exfoliation, Skin Oedema, Stevens-johnson Syndrome
Adverse event was reported on Oct 03, 2007 by a Male patient taking Bufferin (View Usage) (Dosage: ) . Location: JAPAN , 81 years of age, After Bufferin was administered, patient had the following side effects: blister, dry skin, erythema, lip haemorrhage, skin exfoliation, skin oedema, stevens-johnson syndrome. During the same period patient was treated with ACECOL (View Acecol Review and Acecol Label ), LASIX (View Lasix Review and Lasix Label ), LENDORMIN (View Lendormin Review and Lendormin Label ), FRANDOL (View Frandol Review and Frandol Label ). Patient was hospitalized.

5487954-X | Asthenia, Blood Creatinine Increased, Blood Urea Increased, Dehydration, Diarrhoea, Fat Embolism, Fatigue, Livedo Reticularis, Renal Failure
on Oct 03, 2007 Male patient from JAPAN , 65 years of age, was diagnosed with aortic aneurysm (What is aortic aneurysm?) and was treated with Bufferin (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, blood creatinine increased, blood urea increased, dehydration, diarrhoea, fat embolism, fatigue, livedo reticularis, renal failure. Bufferin dosage: . Patient was hospitalized.

5485389-7 | Blister, Dry Skin, Erythema, Lip Haemorrhage, Skin Exfoliation, Skin Oedema, Stevens-johnson Syndrome
on Oct 03, 2007 Male patient from JAPAN , 81 years of age, was treated with Bufferin (View Usage). Patient had the following side effects: blister, dry skin, erythema, lip haemorrhage, skin exfoliation, skin oedema, stevens-johnson syndrome. Bufferin dosage: . During the same period patient was treated with ACECOL (View Acecol Review and Acecol Label ), LASIX (View Lasix Review and Lasix Label ), LENDORMIN (View Lendormin Review and Lendormin Label ), FRANDOL (View Frandol Review and Frandol Label ). Patient was hospitalized.

5485388-5 | Arterial Occlusive Disease, Asthenia, Blood Creatinine Increased, Blood Urea Increased, Cardiac Failure, Dehydration, Dialysis, Diarrhoea, Fat Embolism
Patient was taking Bufferin (View Usage). After Bufferin was administered, patient had the following side effects: arterial occlusive disease, asthenia, blood creatinine increased, blood urea increased, cardiac failure, dehydration, dialysis (What is dialysis?), diarrhoea, fat embolism on Oct 03, 2007 from JAPAN Additional patient health information: Male patient , 65 years of age, was diagnosed with aortic aneurysm (What is aortic aneurysm?) and. Bufferin dosage: . Patient was hospitalized.

5481519-1 | Placenta Accreta, Placenta Praevia
Adverse event was reported on Sep 28, 2007 by a Female patient taking Bufferin (View Usage) (Dosage: ) was diagnosed with in vitro fertilisation and. Location: JAPAN , 54 years of age, weighting 105.8 lb, Patient experienced the following unwanted or unexpected effects: placenta accreta, placenta praevia. During the same period patient was treated with PROGESTERON (View Progesteron Review and Progesteron Label ).

5481511-7 | Antepartum Haemorrhage, Threatened Labour
on Sep 28, 2007 Female patient from JAPAN , 45 years of age, weighting 130.1 lb, was diagnosed with antiphospholipid antibodies positive, uterine contractions abnormal and was treated with Bufferin (View Usage). Patient had the following side effects: antepartum haemorrhage, threatened labour. Bufferin dosage: . During the same period patient was treated with RITODRINE HYDROCHLORIDE (View Ritodrine Hydrochloride Review and Ritodrine Hydrochloride Label ), HEPARIN (View Heparin Review and Heparin Label ). Patient was hospitalized.

5480176-8 | Placenta Accreta, Placenta Praevia
on Sep 28, 2007 Female patient from JAPAN , 54 years of age, weighting 105.8 lb, was diagnosed with in vitro fertilisation and was treated with Bufferin (View Usage). After Bufferin was administered, patient had the following side effects: placenta accreta, placenta praevia. Bufferin dosage: . During the same period patient was treated with PROGESTERON (View Progesteron Review and Progesteron Label ).

5474407-8 | Stevens-johnson Syndrome
Patient was taking Bufferin (View Usage). Patient experienced the following unwanted or unexpected effects: stevens-johnson syndrome on Sep 26, 2007 from JAPAN Additional patient health information: Male patient , 81 years of age, . Bufferin dosage: .

5474406-6 | Fat Embolism
Adverse event was reported on Sep 26, 2007 by a Male patient taking Bufferin (View Usage) (Dosage: ) . Location: JAPAN , 65 years of age, Patient had the following side effects: fat embolism.

5474261-4 | Abortion Of Ectopic Pregnancy, Tubal Ligation
on Oct 01, 2007 Female patient from JAPAN , 32 years of age, was diagnosed with thrombolysis and was treated with Bufferin (View Usage). After Bufferin was administered, patient had the following side effects: abortion of ectopic pregnancy, tubal ligation. Bufferin dosage: . Patient was hospitalized.

5470316-9 | Dizziness, Fall, Lower Limb Fracture, Pain In Extremity, Syncope, Walking Aid User
on Sep 11, 2007 Female patient from BRAZIL , 76 years of age, weighting 180.8 lb, was treated with Bufferin (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), fall (What is fall?), lower limb fracture, pain in extremity, syncope, walking aid user. Bufferin dosage: 1 Df, Qd, Oral. During the same period patient was treated with PROPRANOLOL HYDROCHLORIDE (View Propranolol Hydrochloride Review and Propranolol Hydrochloride Label ), LEXOTAN (BROMAZEPAM) (View Lexotan (bromazepam) Review and Lexotan (bromazepam) Label ), GALVUS MET (View Galvus Met Review and Galvus Met Label ), GLUCOFORMIN (METFORMIN HYDROCHLORIDE) (View Glucoformin (metformin Hydrochloride) Review and Glucoformin (metformin Hydrochloride) Label ). Patient was hospitalized.

5468033-4 | Premature Baby
Patient was taking Bufferin (View Usage). Patient had the following side effects: premature baby on Sep 20, 2007 from JAPAN Additional patient health information: Female patient , weighting 2.36 lb, was diagnosed with antiphospholipid syndrome and. Bufferin dosage: .

5468032-2 | Premature Baby, Premature Separation Of Placenta
Adverse event was reported on Sep 20, 2007 by a Female patient taking Bufferin (View Usage) (Dosage: ) was diagnosed with antiphospholipid syndrome and. Location: JAPAN , 30 years of age, After Bufferin was administered, patient had the following side effects: premature baby, premature separation of placenta.

5468031-0 | Antepartum Haemorrhage
on Sep 20, 2007 Female patient from JAPAN , 28 years of age, was diagnosed with antiphospholipid syndrome and was treated with Bufferin (View Usage). Patient experienced the following unwanted or unexpected effects: antepartum haemorrhage. Bufferin dosage: . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ).

5465444-8 | Placenta Accreta, Placenta Praevia
on Sep 19, 2007 Female patient from JAPAN , 54 years of age, was treated with Bufferin (View Usage). Patient had the following side effects: placenta accreta, placenta praevia. Bufferin dosage: .

5465443-6 | Haematoma, Platelet Count Increased, Pregnancy Induced Hypertension, Premature Labour
Patient was taking Bufferin (View Usage). After Bufferin was administered, patient had the following side effects: haematoma, platelet count increased, pregnancy induced hypertension, premature labour on Sep 19, 2007 from JAPAN Additional patient health information: Female patient , 45 years of age, . Bufferin dosage: .

5465441-2 | Haematoma, Premature Labour
Adverse event was reported on Sep 19, 2007 by a Female patient taking Bufferin (View Usage) (Dosage: ) . Location: JAPAN , 45 years of age, Patient experienced the following unwanted or unexpected effects: haematoma, premature labour.

5465415-1 | Haematoma
on Sep 20, 2007 Female patient from JAPAN , 28 years of age, was diagnosed with antiphospholipid syndrome and was treated with Bufferin (View Usage). Patient had the following side effects: haematoma. Bufferin dosage: . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ).

5465414-X | Premature Baby, Premature Separation Of Placenta
on Sep 20, 2007 Female patient from JAPAN , 30 years of age, was diagnosed with antiphospholipid syndrome and was treated with Bufferin (View Usage). After Bufferin was administered, patient had the following side effects: premature baby, premature separation of placenta. Bufferin dosage: .

5465412-6 | Antiphospholipid Antibodies Positive, Caesarean Section, Premature Baby, Premature Separation Of Placenta, Protein S Decreased
Patient was taking Bufferin (View Usage). Patient experienced the following unwanted or unexpected effects: antiphospholipid antibodies positive, caesarean section, premature baby, premature separation of placenta, protein s decreased on Sep 20, 2007 from JAPAN Additional patient health information: Female patient , weighting 2.36 lb, was diagnosed with antiphospholipid syndrome and. Bufferin dosage: .

5451532-9 | Haemoglobin Decreased, Rectal Cancer, Rectal Haemorrhage
Adverse event was reported on Sep 06, 2007 by a Male patient taking Bufferin (View Usage) (Dosage: Unk) was diagnosed with cerebrovascular accident and. Location: UNITED KINGDOM , weighting 191.8 lb, Patient had the following side effects: haemoglobin decreased, rectal cancer, rectal haemorrhage. During the same period patient was treated with ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), PLAVIX (Unk) (View Plavix Review and Plavix Label ). Patient was hospitalized.

5374309-1 | Atelectasis, Chest Pain, Haemorrhagic Anaemia, Haemothorax, Iatrogenic Injury, Musculoskeletal Pain, Procedural Complication, Prothrombin Time Prolonged
on Jun 27, 2007 Male patient from JAPAN , 56 years of age, was treated with Bufferin (View Usage). After Bufferin was administered, patient had the following side effects: atelectasis, chest pain (What is chest pain?), haemorrhagic anaemia, haemothorax, iatrogenic injury, musculoskeletal pain, procedural complication, prothrombin time prolonged. Bufferin dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

5316410-4 | Toxic Epidermal Necrolysis
on Apr 23, 2007 Female patient from JAPAN , 53 years of age, was diagnosed with nasopharyngitis and was treated with Bufferin (View Usage). Patient experienced the following unwanted or unexpected effects: toxic epidermal necrolysis. Bufferin dosage: . During the same period patient was treated with ALPINY SUPPOSITORIES (ACETAMINOPHEN) (View Alpiny Suppositories (acetaminophen) Review and Alpiny Suppositories (acetaminophen) Label ), LULU (View Lulu Review and Lulu Label ).

5264699-2 | Alanine Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Fibrinogen Increased, Blood Lactate Dehydrogenase Increased, Brain Natriuretic Peptide Increased, Cardiac Failure Congestive, Cardiac Murmur, Dilatation Ventricular
Patient was taking Bufferin (View Usage). Patient had the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, blood fibrinogen increased, blood lactate dehydrogenase increased, brain natriuretic peptide increased, cardiac failure congestive, cardiac murmur, dilatation ventricular on Mar 06, 2007 from JAPAN Additional patient health information: Female patient , 26 years of age, weighting 119.0 lb, was diagnosed with systemic lupus erythematosus, lupus nephritis and. Bufferin dosage: 81 Mg/d. During the same period patient was treated with ONEALFA (0.5 Ug/d) (View Onealfa Review and Onealfa Label ), LASIX (40 Mg/d) (View Lasix Review and Lasix Label ), ZANTAC (150 Mg/d) (View Zantac Review and Zantac Label ), SELBEX (150 Mg/d) (View Selbex Review and Selbex Label ), PREDNISOLONE (25-60 Mg/d) (View Prednisolone Review and Prednisolone Label ), NEORAL (100 Mg/d) (View Neoral Review and Neoral Label ). Patient was hospitalized.

5254214-1 | Brain Natriuretic Peptide Increased, Cardiac Failure Congestive, Dilatation Ventricular, Dyspnoea, Ejection Fraction Decreased, Pulmonary Congestion
Adverse event was reported on Feb 21, 2007 by a Female patient taking Bufferin (View Usage) (Dosage: 81 Mg/d) was diagnosed with systemic lupus erythematosus, lupus nephritis and. Location: JAPAN , 26 years of age, weighting 119.0 lb, After Bufferin was administered, patient had the following side effects: brain natriuretic peptide increased, cardiac failure congestive, dilatation ventricular, dyspnoea, ejection fraction decreased, pulmonary congestion. During the same period patient was treated with ONEALFA (0.5 Ug/d) (View Onealfa Review and Onealfa Label ), LASIX (40 Mg/d) (View Lasix Review and Lasix Label ), ZANTAC (150 Mg/d) (View Zantac Review and Zantac Label ), SELBEX (150 Mg/d) (View Selbex Review and Selbex Label ), PREDNISOLONE (25-60 Mg/d) (View Prednisolone Review and Prednisolone Label ), NEORAL (100 Mg/d) (View Neoral Review and Neoral Label ), VALSARTAN (View Valsartan Review and Valsartan Label ). Patient was hospitalized.

5228270-0 | Aspartate Aminotransferase Increased, Blood Glucose Increased, Blood Lactate Dehydrogenase Increased, C-reactive Protein Increased, Catheterisation Cardiac, Chest X-ray Abnormal, Cough, Haematocrit Decreased, Haemoglobin Decreased
on Jan 24, 2007 Male patient from JAPAN , 77 years of age, weighting 141.1 lb, was diagnosed with acute myocardial infarction, gastric ulcer, diabetes mellitus, hypertension and was treated with Bufferin (View Usage). Patient experienced the following unwanted or unexpected effects: aspartate aminotransferase increased, blood glucose increased, blood lactate dehydrogenase increased, c-reactive protein increased, catheterisation cardiac, chest x-ray abnormal, cough, haematocrit decreased, haemoglobin decreased. Bufferin dosage: 162 Mg/day. During the same period patient was treated with PANALDINE (200 Mg/day) (View Panaldine Review and Panaldine Label ), OMEPRAL (20 Mg/day) (View Omepral Review and Omepral Label ), EUGLUCON (2.5 Mg/day) (View Euglucon Review and Euglucon Label ), DIOVAN (80 Mg/day) (View Diovan Review and Diovan Label ), RENIVACE (5 Mg/day) (View Renivace Review and Renivace Label ). Patient was hospitalized.

5194700-6 | Aspartate Aminotransferase Increased, Blood Glucose Increased, Blood Lactate Dehydrogenase Increased, C-reactive Protein Increased, Catheterisation Cardiac, Chest X-ray Abnormal, Cough, Haematocrit Decreased, Haemoglobin Decreased
on Nov 21, 2006 Male patient from JAPAN , 77 years of age, weighting 141.1 lb, was diagnosed with acute myocardial infarction, gastric ulcer, diabetes mellitus, hypertension and was treated with Bufferin (View Usage). Patient had the following side effects: aspartate aminotransferase increased, blood glucose increased, blood lactate dehydrogenase increased, c-reactive protein increased, catheterisation cardiac, chest x-ray abnormal, cough, haematocrit decreased, haemoglobin decreased. Bufferin dosage: 162 Mg/day. During the same period patient was treated with PANALDINE (200 Mg/day) (View Panaldine Review and Panaldine Label ), OMEPRAL (20 Mg/day) (View Omepral Review and Omepral Label ), EUGLUCON (2.5 Mg/day) (View Euglucon Review and Euglucon Label ), DIOVAN (80 Mg/day) (View Diovan Review and Diovan Label ), RENIVACE (5 Mg/day) (View Renivace Review and Renivace Label ). Patient was hospitalized.

5187980-4 | Cyanosis, Duodenal Ulcer Haemorrhage, Fat Embolism, Pyrexia, Renal Failure Acute
Patient was taking Bufferin (View Usage). After Bufferin was administered, patient had the following side effects: cyanosis, duodenal ulcer haemorrhage, fat embolism, pyrexia, renal failure acute on Dec 11, 2006 from JAPAN Additional patient health information: Male patient , 65 years of age, . Bufferin dosage: . During the same period patient was treated with TICLOPIDINE (View Ticlopidine Review and Ticlopidine Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

5181080-5 | Aspartate Aminotransferase Increased, Blood Glucose Increased, Blood Lactate Dehydrogenase Increased, C-reactive Protein Increased, Catheterisation Cardiac, Chest X-ray Abnormal, Cough, Haematocrit Decreased, Haemoglobin Decreased
Adverse event was reported on Nov 21, 2006 by a Male patient taking Bufferin (View Usage) (Dosage: 162 Mg/day) was diagnosed with acute myocardial infarction, gastric ulcer, diabetes mellitus, hypertension and. Location: JAPAN , 77 years of age, weighting 141.1 lb, Patient experienced the following unwanted or unexpected effects: aspartate aminotransferase increased, blood glucose increased, blood lactate dehydrogenase increased, c-reactive protein increased, catheterisation cardiac, chest x-ray abnormal, cough, haematocrit decreased, haemoglobin decreased. During the same period patient was treated with PANALDINE (200 Mg/day) (View Panaldine Review and Panaldine Label ), OMEPRAL (20 Mg/day) (View Omepral Review and Omepral Label ), EUGLUCON (2.5 Mg/day) (View Euglucon Review and Euglucon Label ), DIOVAN (80 Mg/day) (View Diovan Review and Diovan Label ), RENIVACE (5 Mg/day) (View Renivace Review and Renivace Label ). Patient was hospitalized.

5126614-1 | Brain Oedema, Hepatic Function Abnormal, Hyperammonaemia, Restlessness, Reye's Syndrome, Status Epilepticus
on Oct 10, 2006 Male patient from JAPAN , 32 years of age, was diagnosed with respiratory tract infection and was treated with Bufferin (View Usage). Patient had the following side effects: brain oedema, hepatic function abnormal, hyperammonaemia, restlessness, reye's syndrome, status epilepticus. Bufferin dosage: . During the same period patient was treated with VOLTAREN (Total Daily Dose: 50 Mg Unit Dose: 50 Mg) (View Voltaren Review and Voltaren Label ). Patient was hospitalized.

5094931-X | Feeling Hot, Henoch-schonlein Purpura, Leukocytoclastic Vasculitis, Oedema
on Feb 06, 2006 Male patient from JAPAN , 56 years of age, was treated with Bufferin (View Usage). After Bufferin was administered, patient had the following side effects: feeling hot, henoch-schonlein purpura, leukocytoclastic vasculitis, oedema. Bufferin dosage: . During the same period patient was treated with PANALDINE (View Panaldine Review and Panaldine Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), ATORVASTATIN CALCIUM HYDRATE (View Atorvastatin Calcium Hydrate Review and Atorvastatin Calcium Hydrate Label ), BEZAFIBRATE (View Bezafibrate Review and Bezafibrate Label ). Patient was hospitalized.

5050450-8 | Liver Disorder
Patient was taking Bufferin (View Usage). Patient experienced the following unwanted or unexpected effects: liver disorder on Jun 06, 2006 from JAPAN Additional patient health information: Male patient , 74 years of age, was diagnosed with angina pectoris, stomach discomfort and. Bufferin dosage: . During the same period patient was treated with PEPCID RPD (View Pepcid Rpd Review and Pepcid Rpd Label ), PANALDINE (View Panaldine Review and Panaldine Label ), NITOROL R (View Nitorol-r Review and Nitorol-r Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ). Patient was hospitalized.

4957347-X | Abdominal Haematoma, Abdominal Injury, Arterial Injury, Blood Pressure Systolic Decreased, Fall, Pain, Shock Haemorrhagic
Adverse event was reported on Mar 23, 2006 by a Female patient taking Bufferin (View Usage) (Dosage: Oral) was diagnosed with thrombosis prophylaxis and. Location: JAPAN , 82 years of age, Patient had the following side effects: abdominal haematoma, abdominal injury, arterial injury, blood pressure systolic decreased, fall (What is fall?), pain (What is pain?), shock haemorrhagic. During the same period patient was treated with TICLOPIDINE HCL (Oral) (View Ticlopidine Hcl Review and Ticlopidine Hcl Label ). Patient was hospitalized.

4860883-8 | Anaemia, Cholecystitis, Cholelithiasis, Dyspnoea, Gallbladder Enlargement, Gastrointestinal Haemorrhage, Haemobilia
on Dec 12, 2005 Female patient from JAPAN , 69 years of age, was treated with Bufferin (View Usage). After Bufferin was administered, patient had the following side effects: anaemia, cholecystitis, cholelithiasis, dyspnoea, gallbladder enlargement, gastrointestinal haemorrhage, haemobilia. Bufferin dosage: . Patient was hospitalized.

4809291-6 | Deafness Bilateral, Deafness Neurosensory
on Oct 17, 2005 Female patient from JAPAN , child 4 years of age, was diagnosed with kawasaki's disease and was treated with Bufferin (View Usage). Patient experienced the following unwanted or unexpected effects: deafness bilateral, deafness neurosensory. Bufferin dosage: Oral. During the same period patient was treated with INTRAVENOUS IMMUNOGLOBULINS (IMMUNOGLOBULINS) (Intravenous) (View Intravenous Immunoglobulins (immunoglobulins) Review and Intravenous Immunoglobulins (immunoglobulins) Label ), ULINASTATIN (View Ulinastatin Review and Ulinastatin Label ), CEFOTAX (View Cefotax Review and Cefotax Label ).

4699633-7 | Anaemia, Retroperitoneal Haemorrhage
Patient was taking Bufferin (View Usage). Patient had the following side effects: anaemia, retroperitoneal haemorrhage on Jun 17, 2005 from Additional patient health information: Male patient , 71 years of age, . Bufferin dosage: Oral. Patient was hospitalized.